A detailed history of St Germain D J CO Inc transactions in Incyte Corp stock. As of the latest transaction made, St Germain D J CO Inc holds 2,322 shares of INCY stock, worth $162,911. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,322
Holding current value
$162,911
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 16, 2025

BUY
$55.17 - $71.22 $128,104 - $165,372
2,322 New
2,322 $158,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track St Germain D J CO Inc Portfolio

Follow St Germain D J CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St Germain D J CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on St Germain D J CO Inc with notifications on news.